Home News Pfizer CEO: COVID remains a threat – but they’re ‘calm’ over monkeypox Pfizer CEO: COVID remains a threat – but they’re ‘calm’ over monkeypox Daily Editor May 25, 2022 comments off Tweet on Twitter Share on Facebook Pinterest afford big pharma biontech biotech business coronavirus cost covid covid 19 davos Disease drugs EPIDEMIC global HEALTHCARE incentives infrastructure interview logistics low cost low income countries medicine monkeypox oxford pandemic Paul Kelso pfizer PRICE Research responsibility Sky News SPREAD technology vaccination vaccine variants VIRUS worldwide